Is expensive always better? Comparison of two induction agents for term rupture of membranes

References

• Alfirevic Z. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews 2001; 2: CD001338
   Google Scholar
• Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Human Reproduction 2004; 19: 81–84
   PubMed Web of Science ®Google Scholar
• British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, London 2005
   Google Scholar
• Caliskan E, Bodur H, Ozeren S, Corakci A, Ozkan S, Yucesoy I. Misoprostol 50 mcg sublingually versus vaginally for labour induction at term. Gynecologic and Obstetric Investigation 2005; 59: 155–161
   PubMed Web of Science ®Google Scholar
• Dede F S, Haberal A, Dede H, Sivaslioglu A, Arslanpence I. Misoprostol for cervical ripening and labor induction in pregnancies with oligohydramnios. Gynecologic and Obstetric Investigation 2004; 57: 139–143
   PubMed Web of Science ®Google Scholar
• Farah L A, Sanchez-Ramos L, Rosa C, Del Valle G O, Gaudier F L, Delke I. Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction. American Journal of Obstetrics and Gynecology 1997; 177: 364–371
   PubMed Web of Science ®Google Scholar
• Gregson S, Waterstone M, Norman I, Murrells T. A randomised controlled trial comparing low dose vaginal misoprostol and dinoprostone vaginal gel for inducing labour at term. International Journal of Obstetrics and Gynaecology 2005; 112: 438–444
   Google Scholar
• Hoffmann R A, Anthony J, Fawcus S. Oral Misoprostol vs. placebo in the management of prelabour rupture of membranes at term. International Journal of Gynaecology and Obstetrics 2001; 72: 215–221
   PubMed Web of Science ®Google Scholar
• Imseis H M, Trout W C, Gibbe S G. The microbiological effect of digital cervical examination. American Journal of Obstetrics and Gynecology 1999; 180: 578–580
   PubMed Web of Science ®Google Scholar
• Lo J Y, Alexander J M, McIntire D M, Jeveno K J. Ruptured membranes at term: randomised, double blind trial of oral misoprostol for labour induction. Obstetrics and Gynecology 2003; 10: 685–689
   Google Scholar
• Mckenna D S, Ester J B, Proffitt M, Waddell K R. Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomised trial. Obstetrics and Gynecology 2004; 104: 579–584
   PubMed Web of Science ®Google Scholar
• Muzonzini G, Hofmeyr G. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 2004; 4: CD004221
   Google Scholar
• Ngai S W, Chan Y M, Lam S W, Lao T T. Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. International Journal of Obstetrics and Gynaecology 2000; 107: 222–227
   Google Scholar
• Paungmora N, Herabutya Y, O-Prasertsawat P, Punyavachira P. Comparison of oral and vaginal misoprostol for induction of labour at term: a randomised controlled trial. Journal of Obstetrics and Gynaecology Research 2004; 30: 358–362
   PubMed Web of Science ®Google Scholar
• Ramsey P S, Meyer L, Walkes B A, Harris D, Ogburn P L, Jr, Heise R H. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstetrics and Gynecology 2005; 105: 85–90
   PubMed Web of Science ®Google Scholar
• Rozenberg P, Chevret S, Senat M V, Bretelle F, Paule Bonnal A, Ville Y. A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress. American Journal of Obstetrics and Gynecology 2004; 191: 247–253
   PubMed Web of Science ®Google Scholar
• Schaff E A, Dicenzo R, Fielding S L. Comparison of misoprostol plasma concentration following buccal and sublingual administration. Contraception 2005; 71: 22–25
   PubMed Web of Science ®Google Scholar
• Seaward P G, Hannah M E, Myhr T L, Farine D, Ohlsson A, Wang E E. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. American Journal of Obstetrics and Gynecology 1997; 177: 1024–1029
   PubMed Web of Science ®Google Scholar
• Shetty A, Stewart K, Stewart G, Rice P, Danielian P, Templeton A. Active management of term prelabour rupture of membranes with oral misoprostol. International Journal of Obstetrics and Gynaecology 2002; 109: 1354–1358
   Google Scholar
• Tang O S, Schweer H, Seyberth H W, Lee S W, Ho P C. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction 2002; 17: 332–336
   PubMed Web of Science ®Google Scholar
• Weeks A D, Fiala C, Safar P. Misoprostol and the debate over off-label drug use. International Journal of Obstetrics and Gynaecology 2005; 112: 269–272
   Google Scholar